SCHEMBL27291365

SCHEMBL27291365

CCCCOc1ccc(-c2noc(CC(C(=O)OC(C)(C)C)P(=O)(OCC)OCC)n2)cn1

nearest known ligand 0.37

Predicted protein targets (top 15)

geneUniProtsupporting neighboursconfidence
▸ LTA4H P09960 1/20 0.36
▸ MITF O75030 1/20 0.36
▸ TP53 P04637 1/20 0.36
▸ NCOA3 Q9Y6Q9 1/20 0.36
▸ ACACB O00763 2/20 0.35
▸ ACACA Q13085 1/20 0.35
▸ MAPT P10636 2/20 0.34
▸ SIRT2 Q8IXJ6 1/20 0.34
▸ NPC1 O15118 1/20 0.34
▸ HTT P42858 1/20 0.34
▸ RAB9A P51151 1/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ TSHR P16473 1/20 0.33
▸ PSMB5 P28074 2/20 0.33
▸ PSMB8 P28062 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27291343 0.93 LTA4H (0.35) LTA4HMITFTP53NCOA3ACACB
SCHEMBL23588079 0.90 ACACB (0.46) MITFTP53NCOA3ACACBACACA
SCHEMBL29973090 0.86 MAPK1 (0.38) MITFTP53NCOA3ACACBACACA
SCHEMBL23578484 0.86 MAPK1 (0.38) MITFTP53NCOA3ACACBACACA
SCHEMBL31707538 0.84 HCAR2 (0.35) MITFTP53NCOA3ACACBACACA
SCHEMBL25804667 0.84 SPHK1 (0.43) MITFTP53NCOA3MAPTSIRT2
SCHEMBL30689418 0.84 LTA4H (0.41) LTA4HMITFTP53NCOA3MAPT
SCHEMBL23578218 0.83 SPHK1 (0.47) —
SCHEMBL23588294 0.82 TP53 (0.39) MITFTP53NCOA3MAPTSIRT2
SCHEMBL23588293 0.82 HTT (0.40) MITFTP53NCOA3MAPTSIRT2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4634167-A1 SUBSTITUTED PYRIDINES FOR USE IN TREATING OR PREVENTING INFLAMMATORY DISEASES OR DISEASES ASSOCIATED WITH AN UNDESIRABLE IMMUNE RESPONSE Sitryx Therapeutics Limited (GB) 2025-10-22 — — EP disclosed
WO-2024127030-A1 SUBSTITUTED PYRIDINES FOR USE IN TREATING OR PREVENTING INFLAMMATORY DISEASES OR DISEASES ASSOCIATED WITH AN UNDESIRABLE IMMUNE RESPONSE SITRYX THERAPEUTICS LIMITED (GB) 2024-06-20 — — WO disclosed
Send feedback